Exchange: NASDAQ·Updated 10:50 AM EST
EQ logo

EQ Equillium Inc

$1.43
$0.015
(1.06%)
Today
EarningsNov 12
Mkt Cap$89.41M
Vol38,134.00

About EQ

Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March 2017 and is headquartered in La Jolla, CA.
52

Neutral Sentiment

How do you feel about EQ?

focafoca99
$EQ indicated it received Australian ethics and TGA clearance for its Phase 1 EQ504 trial, with dosing slated for early Nov 2026.
2
focafoca99
$EQ launched a $20M private placement Milestone Closing and dosed first patient in EQ504 trial in Australia.
FriendlyGuy
$EQ they still haven't dosed anyone?? It was due in mid 26 and data in Q1 27? Wtf happened here 🤣🤣

Advertisement|Remove ads.